JPMorgan maintains Neutral rating on Medtronic stock amid renal denervation coverage win – RP Digital

Business

JPMorgan maintains Neutral rating on Medtronic stock amid renal denervation coverage win

July 11, 20251 min0

JPMorgan maintains Neutral rating on Medtronic stock amid renal denervation coverage win

Source link

rpdigital

Leave a Reply Cancel reply

Related Articles

BancFirst declares quarterly dividend and trust interest payment

rpdigitalAugust 28, 20250

Jefferies raises Ollie's Bargain Outlet stock price target to $135 on strong growth

rpdigitalAugust 28, 20250